Simon Whitney L, Salk Hannah M, Ovsyannikova Inna G, Kennedy Richard B, Poland Gregory A
Mayo Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 First Street SW, Rochester, MN 55905, USA.
Immunotherapy. 2014;6(10):1097-112. doi: 10.2217/imt.14.72.
Smallpox was eradicated 34 years ago due to the success of the smallpox vaccine; yet, the vaccine continues to be studied because of its importance in responding to potential biological warfare and the adverse events associated with current smallpox vaccines. Interindividual variations in vaccine response are observed and are, in part, due to genetic variation. In some cases, these varying responses lead to adverse events, which occur at a relatively high rate for the smallpox vaccine compared with other vaccines. Here, we aim to summarize the cytokine responses associated with smallpox vaccine response to date. Along with a description of each of these cytokines, we describe the genetic and adverse event data associated with cytokine responses to smallpox vaccination.
由于天花疫苗的成功,天花在34年前就已被根除;然而,由于其在应对潜在生物战方面的重要性以及与当前天花疫苗相关的不良事件,该疫苗仍在继续研究。观察到疫苗反应存在个体差异,部分原因是基因变异。在某些情况下,这些不同的反应会导致不良事件,与其他疫苗相比,天花疫苗的不良事件发生率相对较高。在此,我们旨在总结迄今为止与天花疫苗反应相关的细胞因子反应。除了对每种细胞因子进行描述外,我们还描述了与天花疫苗接种的细胞因子反应相关的基因和不良事件数据。